FDA Adverse Event Injury Summary report: N

RX ACCULINK CAROTID STENT SYSTEM

MDR report key: 1388076 · Received May 18, 2009

Report

Report Number
3004742046-2009-00119
Event Type
Injury
Date Received
May 18, 2009
Date of Event
May 29, 2007
Report Date
April 24, 2009
Manufacturer
ABBOTT VASCULAR-VASCULAR SOLUTIONS
Product Code
NIM
PMA / PMN Number
P040038
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

STUDY EVENT. THE STENT REMAINS IN THE PT. THE LOT NUMBER WAS PROVIDED. RESTENOSIS OF STENTED SEGMENT IS A KNOWN POTENTIAL ADVERSE EVENT ASSOCIATED WITH THE USE OF THE DEVICE AS LISTED IN THE RX ACCULINK INSTRUCTIONS FOR USE. THERE WAS NO DEVICE MALFUNCTION REPORTED. A REVIEW OF THE FINISH DEVICE LOT HISTORY RECORD DID NOT REVEAL ANY NON-CONFORMITIES WHICH COULD HAVE CONTRIBUTED TO THIS EVENT. DEVICE #1 RX ACCULINK PART # 1011342-30, LOT # 6042051, IS BEING FILED UNDER A SEPARATE MEDWATCH MFR # 3004742046-2009-00118.

Description of Event or Problem · 1

DEVICE #2 (LICA) MALFUNCTION: NONE. SYMPTOMS/ AE: IN-STENT RESTENOSIS. TIME OF AE: APPROXIMATELY 8 MONTHS POST PROCEDURE. IT WAS REPORTED THAT APPROXIMATELY 8 MONTHS POST A LEFT INTERNAL (LICA) AND COMMON CAROTID (LCCA) ARTERY STENTING PROCEDURE IN 2007, THE PT RETURNED TO THE CATHETER LAB FOR TREATMENT OF IN-SENT RESTENOSIS. THE LICA AND 60% IN-SENT RESTENOSIS AND THE LCCA HAD 90% IN-STENT RESTENOSIS. CAROTID ANGIOPLASTY WAS PERFORMED. THERE WAS NO ADVERSE PT SEQUELAE REPORTED. ALTHOUGH REQUESTED, THERE WAS NO ADDITIONAL INFO PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RX ACCULINK CAROTID STENT SYSTEM NIM ABBOTT VASCULAR-VASCULAR SOLUTIONS NA 6081651

Patients

Seq Age Sex Outcome Treatment
1 63 YR Required Intervention DEVICE #1: RX ACCULINK| LOT # 6042051